Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
OXYGENTA PHARMACEUTICAL LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹47.86down ₹0.10 (0.21%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹47.96.
29 Oct: open ₹48.44, high ₹48.50, low ₹47.01
52-week range of traded prices to 29 Oct 2026
₹43.00Low, 11 Jun 2026₹71.59High, 12 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹177 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,615
Oxygenta Pharmaceutical board and management
47 filed, newest first.
Jul 2026
27 Jul · Management
May 2026
Nov 2025
Aug 2025
19 Aug · Management
18 Aug · Management
18 Aug · Management
Jun 2025
20 Jun · Management
20 Jun · Management
20 Jun · Management
20 Jun · Management
Oct 2024
Sep 2024
May 2024
Feb 2024
Oct 2023
Sep 2023
Aug 2023
Jul 2023
Dec 2021
Jul 2021
Feb 2021
Sep 2020
Mar 2020
Apr 2019
Feb 2019
Jan 2019
Dec 2018
Nov 2018
Jan 2018
12 Jan · Management
Jun 2017
22 Jun · Management
Feb 2017
Sep 2016
Mar 2016
23 Mar · Management
Mr. J. Vijay Kumar has filed his resignation due to his personal occupation and board of directors have approved the same in their meeting and he has ....
Oct 2015
12 Oct · Management
Board appointed Mrs. Sudi Vijaya Lakshmi as an Additional Director (Woman Director) of the Company w.e.f. October 12, 2015.